Genetic Drivers of Mosquito Resilience

[1m 28s read]

Mosquito resistance to insecticides is rapidly becoming one of the most critical threats to global public health. As climate change accelerates the spread of invasive mosquito species, extends breeding seasons and sustains high population levels, regions across the world—including Europe—are facing increasing outbreaks of mosquitoborne diseases. More than 80% of the global population now lives in areas at risk, and Greece is experiencing a significant rise in West Nile Virus cases this year. The growing resilience of mosquito populations undermines decades of progress in disease control and raises urgent questions about the effectiveness of current publichealth strategies.

A new study from the Institute of Molecular Biology and Biotechnology (IMBB) at the Foundation for Research and Technology – Hellas (FORTH) provides critical insight into the genetic mechanisms that enable mosquitoes to develop exceptionally high levels of insecticide resistance. The research, published in the Proceedings of the National Academy of Sciences (PNAS) and attached as a PDF to this article, offers a detailed molecular explanation of how different resistance pathways interact and reinforce one another, allowing mosquitoes to neutralize insecticides far more effectively than previously understood.

Led by Dr. Linda Grigoraki and PhD candidate Mengling Chen, the IMBB research team used advanced geneticengineering techniques to examine individual resistance mechanisms, including mutations in insecticide target sites and the overproduction of detoxification enzymes. Their findings reveal that when multiple mechanisms coexist within the same mosquito, resistance increases dramatically. These mechanisms do not operate independently; they act synergistically. Targetsite mutations appear to give detoxification enzymes more time to act, while enzyme complexes may sequentially degrade insecticide molecules, rendering them ineffective. This cooperative action explains why some mosquito populations can withstand even highintensity insecticide exposure.

Professor Yiannis Vontas, Director of IMBB, emphasized the significance of the study, noting that it continues FORTH’s long tradition of pioneering research on insects of publichealth importance and mosquitoborne diseases. The institute has developed extensive international collaborations and trains scientists from around the world in mosquitocontrol strategies. IMBB is also at the forefront of developing molecular diagnostic tools and nextgeneration bioinsecticides aimed at overcoming resistance—efforts supported by the European Union and the Gates Foundation.

As climate pressures intensify and mosquitoborne diseases expand into new regions, the findings of FORTH’s research highlight the urgent need for innovation in publichealth interventions. Understanding the genetic architecture of resistance is essential for designing more effective control strategies and safeguarding populations in Greece, Europe and beyond.